Amy L. McGuire, I. Glenn Cohen, Dominic Sisti, Mason Marks, et. al., JAMA Network As government agencies around the globe contemplate approval of the first psychedelic medicines, many questions remain about their ethical integration into mainstream medical practice. From June 9 to 12, 2023, 27 individuals representing the perspectives of clinicians, researchers, Indigenous groups, industry,…
MDMA, the chemical found in the drug ecstasy, may soon be approved to treat PTSD
npr // Petrie-Flom Center There’s excitement and controversy swirling around the potential use of MDMA for treating post-traumatic stress disorder. By Will Stone and Michel Martin, featuring Mason Marks….
Researchers address key ethics and policy issues in the clinical use of psychedelic therapies
Medical Xpress // Petrie-Flom Center Researchers address key ethics and policy issues in the clinical use of psychedelic therapies. By Taylor Barnes, featuring I. Glenn Cohen….
The State of Psychedelics
Oprah Daily // Petrie-Flom Center Could these mind-altering substances be the cure for the mental health crisis? We unpack the science, the path to acceptance, and the stunning potential. By Liz Brody, featuring Mason Marks….
How to untangle ethics of psychedelics for therapeutic care
Harvard Gazette // Center for the Study of World Religions and Petrie-Flom Center Experts from law, philosophy, spiritual care discuss issues surrounding research, safer use, kicking off Divinity School initiative….
Branching Regulatory Paths and Dead Ends in Psychedelics
I. Glenn Cohen, The Regulatory Review The convergence of current psychedelics regulatory pathways may bring benefits and new challenges….
As California Seeks to Legalize Psychedelics for Therapy, Oregon Provides Key Lessons
KQED // Petrie-Flom Center Obtaining informed consent for psychedelics poses special challenges for practitioners, featuring Petrie-Flom’s Mason MarksCalifornia has an opportunity to massively expand places where people can use psychedelic drugs under supervision, according to a new bill proposing to legalize substances in approved service centers, including psilocybin, MDMA and mescaline for therapeutic use. By Sydney Johnson,…
What Patients Should Know Before Agreeing to Psychedelic Therapy
MedPage Today // Petrie-Flom Center Obtaining informed consent for psychedelics poses special challenges for practitioners, featuring Petrie-Flom’s Mason Marks…
Essentials of Informed Consent to Psychedelic Medicine
Mason Marks, Rebecca W. Brendel, Carmel Shachar, I. Glenn Cohen, JAMA Psychiatry Analysis of the challenges of designing and implementing psychedelic informed consent practices revealed 7 essential components, including the possibility of short- and long-term perceptual disturbances, potential personality changes and altered metaphysical beliefs, the limited role of reassuring physical touch, the potential for patient abuse or coercion, the role and risks…
Treat addiction with psychedelics?
Harvard Gazette // Petrie-Flom Center Despite promise of success stories from patients in recovery, Law School panel cautions that research is lacking on benefits vs. risks…